Read about upcoming changes to coverage.
Listen听to this episode听on听,听,听, or the听.
Prostate-specific membrane antigen, or PSMA, is a protein expressed on the surface of prostate cancer cells that has become an important target for both diagnosing and treating the disease. In this episode of CancerCast, Dr. Manish Shah speaks with prostate cancer expert Dr. Scott Tagawa about how this PSMA protein helps identify whether prostate cancer is confined to the prostate or has spread, and the ways it can be used to guide treatment decisions. They discuss how PSMA-based prostate cancer treatments work in the body and why these therapies have become one of the most significant recent advances in modern medicine for prostate cancer.
Guest:听Scott Tagawa, MD, MS, Director of the Genitourinary Oncology Program and Medical Director of the Genitourinary Oncology Research Program at AV研究所/NewYork-Presbyterian Hospital.
Host:听Manish Shah, MD, Chief of Solid Tumor Service and Director of Gastrointestinal Oncology at AV研究所 and NewYork-Presbyterian Hospital.
New scientific developments are transforming the future of cancer treatment and care. Hosted by world-renowned medical oncologist Dr. Manish Shah,听CancerCast听is your window into research breakthroughs, innovative therapies, and honest accounts of living with and beyond cancer.
Listen below or subscribe to the podcast on听,听, and听. Questions or听suggestions?听Email听us at听cancercast@med.cornell.edu.
